LewisJ.RoseMD
Oncology • Philadelphia, PABreast Cancer, Gastrointestinal Cancer, Hematologic Oncology
Associate Professor, Medical Oncology, Jefferson Medical College-Thos Jefferson Univ
Dr. Rose is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10800 Knights Rd
Philadelphia, PA 19114Phone+1 215-890-3030Fax+1 215-890-3031
Summary
- Dr. Lewis Rose is a seasoned oncologist based in Philadelphia, PA. His subspecialties include breast cancer, gastrointestinal cancer, and hematologic oncology. Trained at prestigious institutions, Dr. Rose graduated from Harvard Medical School in 1978, completed his residency in Internal Medicine at Sidney Kimmel Medical College at Thomas Jefferson University/TJUH, and concluded his fellowship in Hematology and Medical Oncology at University of Pennsylvania Health System. His professional experience includes a tenure as a Clinical Associate Professor of Medical Oncology at Kimmel Cancer Center. Dr. Rose has published work in several renowned journals, and has been cited multiple times by other publications. He has participated in clinical trials targeting various cancers. His services have been honored and recognized by the Patient-Centered Specialty Practice Recognition Program from the National Committee for Quality Assurance and CMS Meaningful Use Stage 1 Certification from Allscripts Enterprise EHR, Allscripts.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1981 - 1984
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1978 - 1981
Harvard Medical SchoolClass of 1978
Certifications & Licensure
DE State Medical License 2017 - 2027
PA State Medical License 1979 - 2026
NJ State Medical License 2017 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
- Top MD Consumers Checkbook
Clinical Trials
- Safety and Efficacy Study of Immunotherapy With Rituximab and Interleukin-2 in Patients With Non-Hodgkin's Lymphoma Start of enrollment: 2009 Feb 05
- A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer Start of enrollment: 2011 May 25
- Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese Patients Start of enrollment: 2011 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsPhase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma.Jonathan Pan, Sushil Ghimire, S. Onder Alpdogan, Andrew E. Chapman, Matthew Carabasi
Leukemia & Lymphoma. 2021-02-23 - 3 citationsCommon Variable Immunodeficiency Disease and Rectal Squamous Cell Carcinoma: a Case Report of a Rare Syndromic Tumor Type.Allison F. Goldberg, Lewis J. Rose, Peter A. McCue
Journal of Gastrointestinal Cancer. 2016-12-01 - 4 citationsColposcopic and cytologic detection of chronic lymphocytic leukemia in the vagina: a case report.Marina Katsnelson, Raeph Laughingwell, Lewis J. Rose, Norman G. Rosenblum
The Journal of Reproductive Medicine. 2011-07-01
Professional Memberships
- Member
Other Languages
- Russian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
